Pharmaceuticals

Plant-Based Vaccines Market Expansion to $9.3 Billion by 2029: Key Drivers and Trends

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plant-based vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Plant-Based Vaccines Market Today And What Will It Reach By 2029?

The market size for cholinergic drugs has experienced steady growth in recent years. It is anticipated to expand from $7.83 billion in 2024 to $8.1 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.4%. Historically, this expansion has been propelled by an increasing aging population, various regulatory approvals, rising healthcare expenditure, and sustained research and development efforts.

The cholinergic drugs market size is expected to show sustained expansion over the coming years. It is projected to increase to “$9.3 billion by 2029”, achieving a compound annual growth rate (CAGR) of 3.5%. The expansion during the forecast period can be attributed to a wider range of applications, economic development in emerging markets, increasing awareness and improved diagnostic capabilities, changes in regulations, and the growing prevalence of chronic illnesses. Significant trends for this period include technological progress, a shift towards sustainable and eco-friendly products, the development of more advanced cholinergic drugs with fewer adverse reactions, an escalation in research and development efforts for medicines, and ongoing technology innovation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16374&type=smp

What Factors Are Boosting The Plant-Based Vaccines Market?

The escalating occurrence of neurological and psychiatric disorders is predicted to stimulate growth in the cholinergic drugs market. Neurological disorders are medical conditions impacting the nervous system, including the brain, spinal cord, and nerves. Psychiatric disorders are mental health conditions that influence an individual’s mood, thought processes, and behavior. The widespread nature of these disorders stems from a combination of genetic, biological, environmental, and psychological factors that disrupt normal brain function and mental processes. Cholinergic drugs assist in treating neurological and psychiatric disorders by amplifying or mimicking acetylcholine’s action, thereby enhancing neurotransmission and easing symptoms related to conditions such as Alzheimer’s disease, myasthenia gravis, and confident mood and anxiety disorders. For instance, in May 2024, the National Center for Biotechnology Information, a US-based Library of Medicine, estimated that the number of Americans aged 65 and older living with Alzheimer’s disease is set to climb from 6.9 million in 2024 to almost 13 million by 2050. Furthermore, in 2024, the National Alliance On Mental Illness, a US-based organization, stated that psychosis spectrum and mood disorders among the U.S. population aged 18-44 lead to nearly 600,000 hospitalizations each year. Consequently, the increasing prevalence of neurological and psychiatric disorders is propelling the growth of the anticholinergic drugs market.

How Is The Plant-Based Vaccines Market Categorized By Application, Type, And Region?

The cholinergic drugs market covered in this report is segmented –

1) By Type: Powder, Tablet, Capsule

2) By Drug Type: Muscarinic Agonists, Nicotinic Agonists, Acetylcholinesterase Inhibitors

3) By Indication: Alzheimer’s Disease, Myasthenia Gravis, Glaucoma, Overactive Bladder, Schizophrenia

4) By Application: Hospital Pharmacy, Retail Pharmacy

Subsegments:

1) By Powder: Oral Powder, Injectable Powder

2) By Tablet: Immediate-Release Tablets, Extended-Release Tablets

3) By Capsule: Soft Gelatin Capsules, Hard Gelatin Capsules

How Are Technological Trends Affecting The Plant-Based Vaccines Market Growth?

Leading companies within the cholinergic drugs market are developing novel products, such as neostigmine methyl sulfate injection, to maintain their competitive edge. Neostigmine methyl sulfate injection functions as a cholinesterase inhibitor, boosting cholinergic activity through preventing acetylcholine degradation. For instance, in June 2023, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, introduced a Neostigmine Methyl sulfate Injection USP in a prefilled syringe. This 3mg/3mL prefilled syringe (PFS), launched in the United States, also operates as a cholinesterase inhibitor. Its specific application is in reversing the effects of nondepolarizing neuromuscular blocking agents (NMBAs) following surgical operations. This innovative offering provides several distinct characteristics aimed at improving the efficiency, precision, and security of neostigmine methyl sulfate administration. The convenience of prefilled syringes is unmatched, as they remove the requirement for manual preparation, lessen preparation time for medical staff, and decrease the likelihood of dosing inaccuracies.

Who Are The Global Leaders Steering The Plant-Based Vaccines Market Forward?

Major companies operating in the cholinergic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Pharmaceutical Co. Ltd., Aurobindo Pharma Limited, Ono Pharmaceutical Co. Ltd., Hikma Pharmaceuticals plc, Lupin Limited, H Lundbeck A/S, Alvogen Inc., Mylan N.V., Nicox S.A, Allergan India Private Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cholinergic-drugs-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Plant-Based Vaccines Market?

North America was the largest region in the cholinergic drugs market in 2024. The regions covered in the cholinergic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16374&type=smp

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795